A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures.

Authors:
Venzi M; Di Giovanni G; Crunelli V.

Journal:
CNS Neurosci Ther

Publication Year: 2014

DOI:
10.1111/cns.12337

PMCID:
PMC4335601

PMID:
25403866

View on PubMed View on PMC View Publisher
Journal Information

Full Title: CNS Neurosci Ther

Abbreviation: CNS Neurosci Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aberrant microstructural integrity of white matter in mild and severe orthostatic hypotension: A NO…
Cheng Y; Lin L; Jiang S and 6 more (2024) - Transparency Score: 3/6
Absence in CX3CR1 receptor signaling promotes post-ischemic stroke cognitive function recovery thro…
Ge Y; Yang J; Chen J and 5 more (2024) - Transparency Score: 3/6
Acetyl-11-keto-beta-boswellic acid modulates macrophage polarization and Schwann cell migration to …
Wang Y; Xiong Z; Qiao Y and 6 more (2024) - Transparency Score: 3/6
Activation of testosterone-androgen receptor mediates cerebrovascular protection by photobiomodulat…
Feng Y; Huang Z; Ma X and 6 more (2024) - Transparency Score: 3/6
Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization.
He Q; Wang Y; Fang C and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest The authors declare no conflict of interest."

Evidence found in paper:

"Our work in this area is supported by the Wellcome Trust (grants 91882 and 93763), the MRC (grant G0900671), and Epilepsy Research UK (grant P1202)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025